Profile

Amber M. Reeves-Daniel, D.O.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Amber M. Reeves-Daniel, D.O.

Associate Professor,

Clinical Interests

Nephrology, Renal Transplantation, Kidney Disease (Chronic), Kidney Disease, Kidney Donors, Kidney Disease in African Americans, Solitary Kidney, Clinical Nephrology

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4458
Department: 336-716-4650

Insurance Accepted »

Education & Training

  • D.O., Oklahoma State Univ College Osteopathic Medicine, 2001
  • Residency, Internal Medicine, North Carolina Baptist Hospita, 2004
  • Internship, Internal Medicine, North Carolina Baptist Hospita, 2006
  • Fellowship, Nephrology, WFU School of Medicine, 2006

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology

Memberships

  • Am Soc Of Nephrology
  • Am Soc of Transplantation

NPI Number

  • 1184709370
Amber M. Reeves-Daniel, D.O.

Doctor Rating

No Rating Available
Why No Ratings?

Amber M. Reeves-Daniel, D.O.

Associate Professor, Nephrology

Research Interests

Kidney Transplantation; Living Donors; Kidney Failure, Chronic; Insurance Coverage; Health Services Accessibility
More »

Contact Information

Academic: 336-716-4458 | Department: 336-716-4650

Recent Publications

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J.. Clin Transplant. 2016;30(4):380-392.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

Factors influencing racial disparities in renal transplantation outcomes [abstract]. Mohan S, Freedman BI, Brown WM, Pastan SO, Israni AK, Schladt DP, Gaston RS, Bray R, Reeves-Daniel AM, Julian BA, Divers J.. J Am Soc Nephrol. 2015;26(Abstract Suppl):609A.

Effect of changing African American race to Apolipoprotein L1 genotype on kidney donor risk index [abstract]. Julian BA, Gaston RS, Freedman BI, Brown WM, Reeves-Daniel AM, Israni AK, Schladt DP, Pastan SO, Mohan S, Divers J.. J Am Soc Nephrol. 2015;26(Abstract Suppl):49A.

Analysis of patient refusals for transplantation [abstract]. Reeves-Daniel A, Palanisamy A, Orlando G, Rogers J, Russell G, Farney A, Burkart J, Stratta R, Freedman B.. Am J Transplant. 2015;15(Suppl 3):1761.

Import pancreas transplants: good from far or far from good? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S, Stratta R.. Am J Transplant. 2015;15(Suppl 3):1068.

The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects. Palanisamy A, Reeves-Daniel AM, Freedman BI.. Pediatr Nephrol. 2014;29(9):1485-1492.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J.. Transplantation. 2014;98(Suppl 1):631.

Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):855.

Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

Pancreas transplantation in African American compared to non African American patients: does recipient ethnicity influence outcomes? [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

Similar results with solitary pancreas transplantation compared to simultaneous pancreas-kidney transplantation in the new millennium [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):854.

Does donor ethnicity influence kidney transplant outcome after simultaneous kidney-pancreas transplantation? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Winfrey S, Uloko V, Bodner J, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Freedman B, Stratta R.. Transplantation. 2014;98(Suppl 1):861.

Single center analysis of mortality in 202 consecutive pancreas transplants [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):860.

What we do and don't understand about pancreas graft failure [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):863.

Expanded criteria donors: the end of an era [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Rogers J.. Transplantation. 2014;98(Suppl 1):654.

Experience with deceased donor kidney transplantation in 114 septuagenarians [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Rogers J.. Transplantation. 2014;98(Suppl 1):600.

5 year results of a prospective, randomized single center study of alemtuzumab compared to rabbit anti-thymocyte gobulin induction in simultaneous kidney-pancreas transplantation [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Farney A.. Transplantation. 2014;98(Suppl 1):215.

Dual kidney transplants from adult marginal donors: double or nothing [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Farney A.. Transplantation. 2014;98(Suppl 1):595-596.

Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. Clin Transplant. 2014;28(12):1372-1382.

Pancreas transplantation: the Wake Forest experience in the new millennium. Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ.. World J Diabetes. 2014;5(6):951-961.

A population-based study of the U.S. population shows the majority of persons cannot donate due to preventable diseases and socio-economic conditions [abstract]. Bleyer AJ, Reeves-Daniel AM.. J Am Soc Nephrol. 2014;25(Abstract Suppl):67A.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure [abstract]. Freedman BI, Julian BA, Pastan SO, Israni AK, Kirk AD, Gaston RS, Stratta RJ, Mohan S, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J.. J Am Soc Nephrol. 2014;25(Abstract Suppl):40A.

Variation in the multidrug resistance protein 1 gene (ABCB1) in African American deceased organ donors is associated with renal allograft failure [abstract]. Ma J, Divers J, Palmer ND, Julian BA, Pastan SO, Israni AK, Gaston RS, Ma L, Stratta RJ, Palanisamy A, Reeves-Daniel AM, Freedman BI.. J Am Soc Nephrol. 2014;25(Abstract Suppl):40A.

Transplantation of CDC high risk kidneys: a low risk option for a high risk problem [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Gautreaux M, Winfrey S, Uloko V, Iskandar S, Brim E, Hairston G, Stratta R.. Am J Transplant. 2013;13(Suppl 5):403.

Ethnicity, medical insurance, and living kidney donation. Reeves-Daniel AM, Farney AC, Fletcher AJ, Assimos D, Westcott C, Rogers J, Stratta RJ, Rocco MV, Freedman BI.. Clin Transplant. 2013;27(4):E498-E503.

Similar results with solitary pancreas compared to simultaneous kidney-pancreas transplantation in the new millennium [abstract]. Rogers J, Farney A, Iskandar S, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Gautreaux M, Stratta RJ.. Transplantation. 2013;96(6 Suppl):S11.

5 year results of a prospective randomized single center study of alemtuzumab compared to rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation [abstract]. Stratta RJ, Rogers J, Hart L, Doares W, Kaczmorski S, Reeves-Daniel A, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Iskandar S, Farney A.. Transplantation. 2013;96(6 Suppl):S86.

Single center analysis of mortality in 202 consecutive pancreas transplants [abstract]. Stratta RJ, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Rogers J.. Transplantation. 2013;96(6 Suppl):S87.

Child-to-parent donation-consideration of age and ethnicity [letter]. Reeves-Daniel AM, Freedman BI.. Am J Transplant. 2012;12(2):502.

Breakthrough CMV infection rates are similar using low dose vs. standard dose valganciclovir in high risk D+/R- kidney or kidney/pancreas transplantation [abstract]. Kaczmorski S, Doares W, Winfrey S, Uloko V, McArthur M, Reeves-Daniel A, Ghanta M, Rogers J, Farney A, Stratta R.. Am J Transplant. 2012;12(Suppl 3):470.

Race, insurance status, and living kidney donation [abstract]. Reeves-Daniel AM, Farney A, Fletcher A, Assimos DG, Westcott CJ, Ghanta M, Stratta RJ, Rogers J, Rocco MV, Freedman BI.. Am J Transplant. 2012;12(Suppl 3):332.

Proportionate nephron mass according to deceased donor category and type of transplant: influence of delayed graft function and acute rejection [abstract]. Stratta RJ, Farney A, Reeves-Daniel A, Ghanta M, Orlando G, Rogers J.. Am J Transplant. 2012;12(Suppl 3):500.

Does alemtuzumab induction and negative flow cytometry crossmatching abrogate the need for early graft biopsies in the setting of delayed graft function? [abstract]. McArthur MC, Iskandar S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J.. Am J Transplant. 2012;12(Suppl 3):372.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Rogers J, Farney A, Orlando G, Brim E, Hairston G, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Winfrey S, McArthur MC, Uloko V, Stratta R.. Am J Transplant. 2012;12(Suppl 3):246-247.

Influence of donor and recipient ethnicity on outcomes following deceased donor kidney transplantation [abstract]. Winfrey SA, Al-Geizawi S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J.. Am J Transplant. 2012;12(Suppl 3):524.

Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Freedman BI, Langefeld CD, Turner J, Nunez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J.. Kidney Int. 2012;82(7):805-811.

Experience with deceased donor kidney transplantation in patients over age 70: is rationing justified? [abstract]. Algeizawi S, Farney A, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams P, Stratta R.. Am J Transplant. 2011;11(Suppl 1):74.

Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. Singh RP, Farney AC, Rogers J, Zuckerman J, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta RJ.. Clin Transplant. 2011;25(2):255-264.

The APOL1 gene and allograft survival after kidney transplantation. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI.. Am J Transplant. 2011;11(5):1025-1030.

Effect of high donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants (DDKT) [abstract]. Algeizawi S, Farney A, Rogers J, Gautreaux M, Doares W, Kaczmorski S, Winfrey S, Ghanta M, Reeves-Daniel A, Adams P, Stratta R.. Am J Transplant. 2011;11(Suppl 2):228.

Are HIV-positive patients at higher risk for BK viral infection following kidney transplantation? [abstract]. Kaczmorski S, Doares W, Al-Geizawi S, Gautreaux M, Reeves-Daniel A, Adams P, Ghanta M, Rogers J, Farney A, Stratta R.. Am J Transplant. 2011;11(Suppl 2):259.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Nephrology

Clinical Interests

Nephrology, Renal Transplantation, Kidney Disease (Chronic), Kidney Disease, Kidney Donors, Kidney Disease in African Americans, Solitary Kidney, Clinical Nephrology
Amber M. Reeves-Daniel, D.O.

Amber M. Reeves-Daniel, D.O.

Associate Professor, Nephrology

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.6
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
3.5



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

1/7/2016

Service & information was excellent.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.